Effect of azithromycin in combination with simvastatin in the treatment of chronic obstructive pulmonary disease complicated by pulmonary arterial hypertension

Pakistan Journal of Medical Sciences

Volumn 33, Issue 2, 2017, Pages 260-264

  Wang, Peidong ^a   Yang, Jie ^a   Yang, Yanwei ^a   Ding, Zhixin ^a  

^a Zhengzhou Hospital of Traditional Chinese Medicine   (China)

Author keywords

Azithromycin; COPD; Simvastatin

Indexed keywords

AZITHROMYCIN; LIPID; SIMVASTATIN;

ADULT; AGED; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD GAS ANALYSIS; BLOOD OXYGEN TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OBSERVATION; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; DYSPNEA; ENTERIC COATED TABLET; EVENING DOSAGE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LIPID BLOOD LEVEL; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SIX MINUTE WALK TEST; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 85018475831     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.332.11717     Document Type: Article

References (16)

1. Chen X, Liu K, Wang Z, Zhu Y, Zhao Y, Kong H, et al. Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2015;10:2525-2533. doi:10.2147/COPD.S94211
2. Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, et al. Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias. PLoS One. 2015;10(12):e0141911. doi:10.1371/journal. pone.0141911
3. Guo S, Feng Z. Galectin-3 mediates the effect of PDGF on pulmonary arterial hypertension. Int J Clin Exp Med. 2015;8(9):15302-15307.
4. Peinado VI, Gómez FP, Barberà JA, Roman A, Angels Montero M, Ramírez J, et al. Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant. J Heart Lung Transplant. 2013;32(12):1262-1269. doi:10.1016/j.healun.2013.09.007
5. Carlsen J, Hasseriis Andersen K, Boesgaard S, Iversen M, Steinbrüchel D, Bøgelund Andersen C. Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease. J Heart Lung Transplant. 2013;32(3):347-354. doi:10.1016/j.healun.2012.11.014
6. Chen WY, Ke H. Statins and angiotensin II receptor antagonist in the treatment of chronic obstructive pulmonary disease. West Chin Med J. 2012;27(2):300-303.
7. Zhang SR. Clinical effect of ambroxol hydrochloride aerosol inhalation in adjuvant treatment of chronic obstructive pulmonary disease. Chin Remed Clin. 2012;12(2):221-222. doi:10.3969/j.issn.1671-2560.2012.02.036
8. Zhao XM, Xu CP, Zeng B, Du GY, Wang XD. Effects of atorvastatin and sildenafil combined treatment in patients with pulmonary hypertension caused by chronic obstructive pulmonary disease. Med Inform. 2010;5(10):2673-2675. doi:10.3969/j.issn.1006-1959.2010.10.009
9. Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di Sciascio G, Covino E. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg. 2007;83(4):1374-1380. doi:10.1016/j.athoracsur.2006.10.065
10. Wang LH, Zhang WP, Jiang WX, Qian YE. Image and hemodynamical features of pulmonary artery branches in COPD with pulmonary artery hypertension. J Zhejiang Univ (Med Sci). 2010;39(6):377-379. doi:10.3785/j.issn.1008-9292.2010.06.008
11. Zhang W, Gao F. New progress on the treatment of chronic obstructive pulmonary disease in combination with pulmonary arterial hypertension. Mod J Integr Chin Tradit West Med. 2012;21(11):1253-1254. doi:10.3969/j.issn.1008-8849.2012.11.072
12. Shen H, Shen C. Research progress of immunomodulatory effects of macrolide drugs. Sect Respirat Syst Foreign Med Sci. 2005;25(11):818-821. doi:10.3760/cma.j.issn.1673-436X.2005.11.007
13. Agusti A, Faner R. Systemic inflammation and comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2012;9(2):43-46. doi:10.1513/pats.201108-050MS
14. Kosanovic D, Dahal BK, Peters DM, Seimetz M, Wygrecka M, Hoffmann K, et al. Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease. Pulm Circ. 2014;4(1):128-136. doi:10.1086/675642
15. Noteboom B, Jenkins S, Maiorana A, Cecins N, Ng C, Hill K. Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2014;34(1):75-79. doi:10.1097/HCR.0000000000000036
16. Pang Y, Qi GJ, Li XY. Simvastatin combined with low-dose macrolide treatment of chronic obstructive pulmonary disease evaluation. Guid Chin Med. 2014;12(10):6-7.